Company Overview

MedNord AB is a dynamic and forward-thinking pharmaceutical intermediary company based in Sweden. We specialize in connecting leading Swedish pharmaceutical manufacturers with healthcare providers and distributors across Africa. Our goal is to ensure that innovative and life-saving medications for rare and oncological diseases are accessible to those who need them most. Leveraging over a decade of expertise in medical research and a robust professional network, MedNord AB is committed to enhancing global health through strategic partnerships and efficient supply chain management.

Our Mission

At MedNord AB, our mission is to bridge the gap between cutting-edge Nordic pharmaceutical innovations and the urgent medical needs in Africa. We strive to facilitate the seamless distribution of high-quality medications, thereby improving healthcare outcomes and contributing to the global fight against rare and oncological diseases. Our commitment to excellence, integrity, and collaboration drives us to deliver unparalleled service and value to our partners and clients.

Our History

Founded in 2024 by Wiem Chaabane, MedNord AB emerged from a passion for improving access to essential medications and a deep understanding of the medical research landscape. With over ten years of experience in oncology research and a strong network within the Swedish pharmaceutical industry, Wiem recognized the need for a dedicated intermediary to connect Swedish pharmaceutical innovations with the African market. Since its inception, MedNord AB has rapidly grown, forging strong partnerships and establishing itself as a trusted player in the pharmaceutical distribution sector.

Our Team

MedNord AB is driven by a team of dedicated professionals with diverse backgrounds in medical research, pharmaceuticals, and international business. Our collective expertise and shared vision enable us to effectively navigate the complexities of the pharmaceutical supply chain and regulatory landscapes.